ALGAE.PA Fermentalg SA

Healthcare Biotechnology Euronext Paris
0.3800 EUR
Close of Nov 7, 2026
0.3505 0.6400
Market cap
EUR 45.5M
P/E
-
P/B
1.43x
ROE
-52.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is ALGAE.PA undervalued?

Graham number

The Graham number of Fermentalg SA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fermentalg SA fundamental analysis

No fundamental analysis for Fermentalg SA yet.

Fermentalg SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fermentalg SA

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 20…

Full company profile